RecruitingNot ApplicableNCT07470684

Skin Involvement in Dupuytren Surgical Treatment Outcome

Skin Involvement in Dupuytren Surgical Treatment Outcome: Interventional Study on Prognostic Value of Cutometry, Ultrasound and Histopathology


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

50 participants

Start Date

Dec 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Palmar skin is often retracted in Dupuytren disease (DD), making surgical management challenging and skin-preserving surgery difficult. Based on clinical experience in DD surgery and outcome, it is suspected that recurrence may be associated with such retracted skin. Possibly, this is due to presence and persistence of aligned myofibroblasts (MF), fixed to the deepest dermal layers. This interventional study aims to investigate the pathophysiological involvement of palmar skin in Dupuytren disease, and its implications for prognostics and treatment.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Microbiopsy for histological analysis, Suction cutometry, and others for people with dupuytren disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTSuction cutometry

Suction cutometry is a non-invasive evaluation tool which is used to assess skin elasticity objectively and quantitatively.

DIAGNOSTIC_TESTUltrasound measurement

Ultrasound measurement of distance between skin surface and underlying Dupuytren tissue

PROCEDUREMicrobiopsy for histological analysis

During microfasciectomy, the surgeon will perform a single-5mm microbiopsy of DD nodules with overlying skin in all patients. These biopsies will be preserved in the UZ/KU Leuven Biobank and immunohistochemical analyses will be performed.


Locations(1)

Universitaire Ziekenhuizen KU Leuven

Leuven, Vlaams-Brabant, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07470684


Related Trials